Zoetis Inc. is a global leader in animal health, dedicated to supporting the health and well-being of animals through innovative products and services. The company's mission is to empower veterinarians and livestock producers with solutions that enhance animal health and productivity. Zoetis focuses on research and development to create a diverse portfolio of vaccines, medicines, and diagnostic tools for both companion animals and livestock. Its strategy emphasizes sustainability, collaboration with stakeholders, and leveraging advanced technologies to meet the evolving needs of the animal health market, ultimately improving the quality of life for animals and the people who care for them.

ZOETIS INC

Zoetis has made significant strides in addressing the ongoing avian influenza crisis that has impacted poultry and led to soaring egg prices. As of February 20, 2025, the company recently received a conditional license from the U.S. Department of Agriculture (USDA) for a new avian influenza vaccine, designed specifically to...

Zoetis Secures Conditional USDA License for Avian Influenza Vaccine Amid Bird Flu Crisis and Rising Egg Prices

Zoetis has taken a major step in the fight against avian influenza by securing a conditional USDA license for a new vaccine, shifting the focus from culling to vaccination. Can this innovative approach effectively stabilize the poultry industry and alleviate rising egg prices?